Top compounds associated with response to THBD


Feature Type Standardized
Nominal ANOVA
mRNA bid1870 gCSI pan-cancer AAC 0.29 8e-07
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.14 3e-05
mRNA FK866 GDSC1000 pan-cancer AAC -0.13 8e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA PD318088 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA AUY922 GDSC1000 pan-cancer AAC 0.13 0.0005
Download CSV